Principal Financial Group Inc. Acquires 7,932 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Principal Financial Group Inc. boosted its holdings in Avanos Medical, Inc. (NYSE:AVNS) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 237,794 shares of the company’s stock after purchasing an additional 7,932 shares during the quarter. Principal Financial Group Inc. owned about 0.52% of Avanos Medical worth $3,786,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. KBC Group NV increased its holdings in shares of Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after acquiring an additional 1,095 shares in the last quarter. New York State Teachers Retirement System increased its holdings in shares of Avanos Medical by 2.0% during the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock valued at $1,737,000 after acquiring an additional 1,388 shares in the last quarter. Quarry LP bought a new stake in shares of Avanos Medical during the third quarter valued at approximately $42,000. Foundry Partners LLC increased its holdings in shares of Avanos Medical by 1.1% during the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,800 shares in the last quarter. Finally, Natixis Advisors LLC increased its holdings in shares of Avanos Medical by 13.6% during the third quarter. Natixis Advisors LLC now owns 21,452 shares of the company’s stock valued at $515,000 after acquiring an additional 2,574 shares in the last quarter. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Trading Down 0.5 %

NYSE AVNS opened at $15.05 on Wednesday. The company has a market cap of $692.35 million, a price-to-earnings ratio of 44.26 and a beta of 1.17. Avanos Medical, Inc. has a 52 week low of $14.40 and a 52 week high of $25.36. The business has a 50 day moving average price of $16.08 and a 200-day moving average price of $19.53. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. The firm had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. As a group, equities analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.